Joseph Cabral, PhD

Joseph Cabral, PhD is an accomplished scientist in the field of virology with experience in leading vector engineering teams for gene therapy payload delivery. Joseph's career spans across various prestigious companies such as Ring Therapeutics, Biogen, Voyager Therapeutics, and Harvard University where Joseph conducted significant research on epigenetic restriction of herpes simplex virus gene expression. With a strong background in molecular biology and a PhD in Virology from Harvard University, Joseph's expertise and contributions have led to the submission of multiple patent applications in the field of gene therapy.